LMR Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-400,000
Closed -$3.26M 1222
2024
Q3
$3.26M Buy
+400,000
New +$2.64M 0.03% 469
2023
Q2
Sell
-202,418
Closed -$1.64M 914
2023
Q1
$1.64M Buy
202,418
+157,414
+350% +$1.26M 0.03% 476
2022
Q4
$282K Buy
+45,004
New +$314K ﹤0.01% 958
2022
Q3
Sell
-485,956
Closed -$3.38M 1214
2022
Q2
$4.06M Sell
485,956
-197,733
-29% -$2.76M 0.07% 317
2022
Q1
$15.6M Buy
683,689
+356,999
+109% +$8.73M 0.18% 116
2021
Q4
$9.02M Hold
326,690
0.09% 174
2021
Q3
$9.1M Hold
326,690
0.1% 171
2021
Q2
$9.58M Buy
+326,690
New +$9.9M 0.14% 136
2016
Q2
Sell
-111,208
Closed -$2.91K 479
2016
Q1
$2.91K Buy
+111,208
New +$8.22M 0.32% 45
2015
Q2
Sell
-4,358
Closed -$859K 529
2015
Q1
$859K Sell
4,358
-6,557
-60% -$1.16M 0.12% 213
2014
Q4
$1.56M Buy
+10,915
New +$1.47M 0.2% 132

Other funds holding BHC

LMR Partners's BHC Position: Q4 2024 in Review

LMR Partners sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 400,000 shares — an estimated $3.26M sold.

LMR Partners first reported a position in BHC in Q4 2014 and held it in 11 quarters. The position peaked at $15.6M in Q1 2022. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.

  • LMR Partners reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
  • LMR Partners sold 400,000 Bausch Health shares in Q4 2024, an estimated $3.26M.
  • LMR Partners first reported a position in Bausch Health in Q4 2014 and held it in 11 quarters.
  • LMR Partners's Bausch Health position peaked at $15.6M in Q1 2022.
  • 225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.

Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.